Please Wait
Applying Filters...
menu
    • menu
    Trusted Global CDMO Partner Delivering End-to-End Pharma Manufacturing & Development Solutions.

    Virtual Booth

    Contact Supplier

    Evonik Health Care is the innovation hub for leading life science companies

    Virtual Booth

    Contact Supplier

    Aarti Pharmalabs is a partner of choice for pharmaceutical companies for APIs & Intermediates. Largest Indian producer of Caffeine.

    Virtual Booth

    Contact Supplier

    Axplora is your partner of choice for complex APIs.

    Virtual Booth

    Contact Supplier

    Munit offers scalable GMP micronization and particle size engineering to enhance drug solubility, bioavailability, and performance.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-2026-02-09

    Virtual Booth

    An Enquiry

    Menu

    Allylestrenol

    ACTIVE PHARMA INGREDIENTS

    FINISHED DOSAGE FORMULATIONS

    DIGITAL CONTENT

    MARKET PLACE

    PharmaCompass
    $ API Ref.Price (USD/KG) : 1,786Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Organon VTAMA Ph 3 Data Show Early Sleep Gains in Pediatric AD
    Organon VTAMA Ph 3 Data Show Early Sleep Gains in Pediatric AD

    27 Feb 2026

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20260227912195/en/New-Analysis-of-Organons-VTAMA-tapinarof-cream-1-Phase-3-Data-Showed-Early-and-Consistent-Improvement-in-Patient-Reported-Sleep-Subdomains-in-Pediatric-Patients-Down-to-2-Years-of-Age-with-Atopic-Dermatitis

    BUSINESSWIRE
    27 Feb 2026
    Share Share
    Organon Releases Q4 And Full-Year 2025 Results
    Organon Releases Q4 And Full-Year 2025 Results

    12 Feb 2026

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20260212249326/en/Organon-Reports-Results-for-the-Fourth-Quarter-and-Full-Year-Ended-December-31-2025

    BUSINESSWIRE
    12 Feb 2026
    Share Share
    Organon Reports Q4, Full-Year 2025 Results Feb. 12
    Organon Reports Q4, Full-Year 2025 Results Feb. 12

    29 Jan 2026

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20260129138194/en/Organon-To-Report-Fourth-Quarter-and-Full-Year-2025-Results-and-Host-Conference-Call-on-February-12-2026

    BUSINESSWIRE
    29 Jan 2026
    Share Share
    Sun Pharma Looks To Rise In US With $10 Billion Organon Buy
    Sun Pharma Looks To Rise In US With $10 Billion Organon Buy

    18 Jan 2026

    // ECONOMICTIMES

    https://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/sun-pharma-looks-to-rise-inus-with-10-billion-organon-buy/articleshow/126660959.cms

    ECONOMICTIMES
    18 Jan 2026
    Share Share
    Organon Announces FDA Approval of sNDA Extending Use of Nexplanon
    Organon Announces FDA Approval of sNDA Extending Use of Nexplanon

    17 Jan 2026

    // PHARMIWEB

    https://www.pharmiweb.com/press-release/2026-01-17/organon-announces-us-food-and-drug-administration-approval-of-supplemental-new-drug-application-exte

    PHARMIWEB
    17 Jan 2026
    Share Share
    Organon To Present At Piper Sandler Healthcare Conference
    Organon To Present At Piper Sandler Healthcare Conference

    25 Nov 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20251125341955/en/Organon-To-Present-at-the-Piper-Sandler-37th-Annual-Healthcare-Conference

    BUSINESSWIRE
    25 Nov 2025
    Share Share
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.